AdaptHealth Corp. (AHCO) stock
Close on Nov 13, 2026Market cap $1.04BP/E –Yield –
AdaptHealth Corp. grew revenue 20.7% to $3.58B over the twelve months to Sep 30, 2026. Operating income fell 239.1% to -$319.84M, moving the operating margin from 7.8% to -8.9%. Free cash flow was $81.92M, down 61.6% from a year earlier. At the latest close the market valued the company at $1.04B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $1.04B
- P/E ratio
- –
- Price to sales
- 0.29
- Price to book
- 0.85
- Dividend yield
- –
- Free cash flow yield
- 7.84%
Fundamentals
- Revenue
- $3.58B
- Net income
- -$406.73M
- EPS, diluted
- -$3.01
- Free cash flow
- $81.92M
- Book value per share
- $8.99
- Diluted shares
- 136M
Trading
- Next earnings
- Feb 23, 2027 (estimated, before the open)
- Previous close
- $7.87
- Open
- $7.87
- Day's range
- $7.61 – $7.96
- Volume
- 2,188,132
- Average volume (20 days)
- 2,801,587
- Index membership
- S&P SmallCap 600 (since Aug 2022), Russell 2000 (since Jun 2020), Russell 3000 (since Aug 2020)
- Beta (5 years)
- 0.72
- 52-week range
- $5.21 – $13.43
- RSI (14 days)
- 70.5
- Volatility (1 year)
- 62.2%
- Relative volume
- 0.78×
- WACC
- 6.7%
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2018, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | AHCO | S&P 500 | Difference | AHCO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +21.0% | -3.0% | +24.0 pts | ||
| 3 months | +34.4% | -2.8% | +37.2 pts | ||
| Year to date | -23.1% | +11.5% | −34.6 pts | ||
| 1 year | -17.9% | +13.5% | −31.4 pts | ||
| 3 years | +1.1% | +77.7% | −76.6 pts | +0.4% | +21.1% |
| 5 years | -69.6% | +72.6% | −142.2 pts | -21.2% | +11.5% |
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases AdaptHealth filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Update
- Results
About AdaptHealth
Services-Home Health Care Services
AdaptHealth Corp. provides home healthcare solutions, medical equipment, and related supplies directly to patients. The company operates through four reportable segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home. Its offerings include sleep therapy devices, oxygen and mechanical ventilation systems, continuous glucose monitors, insulin pumps, and home medical supplies for individuals managing chronic conditions or recovering after hospital discharge. Its customer base consists of patients covered by Medicare, Medicaid, and commercial health insurance plans, receiving referrals from hospitals, specialized clinics, and physicians.
Company profile, executives and historyAdaptHealth stock: common questions
What is AdaptHealth's stock price?
AHCO closed at $7.66 on Nov 13, 2026, down 2.67% on the day. Over the past 52 weeks it traded between $5.21 and $13.43.
What is AdaptHealth's market cap?
AdaptHealth was worth $1.04B at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is AHCO's P/E ratio?
AdaptHealth lost money over the twelve months to Sep 30, 2026 (diluted EPS -$3.01), so it has no meaningful P/E ratio.
How much revenue does AdaptHealth make?
AdaptHealth reported revenue of $3.58B for the twelve months to Sep 30, 2026, up 20.7% from a year earlier.
Does AdaptHealth pay a dividend?
No. AdaptHealth has not paid a cash dividend over the last twelve months.
When does AdaptHealth report earnings next?
AdaptHealth is expected to report Q4 FY2026 results on Feb 23, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has AHCO stock performed over the past year?
Including dividends, AHCO returned -17.9% over the past year, against +13.5% for the S&P 500.
How many AHCO shares are sold short?
11M shares were sold short at the latest FINRA report, 9.40% of the float, or 5.2 days of average trading volume.
Who are AdaptHealth's competitors?
Companies most similar to AdaptHealth by business, industry and size include AVAH, OPCH, ADUS, BTSG, CHE.
See a number that looks wrong?